Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
IGF-1 LR3 has been modified to resist binding to IGF-binding proteins, dramatically increasing its half-life and bioavailability in research settings
Three global clinical studies on IcoSema have been completed that show promise for the potential combination medication
GLP-1 drugs do the same
Effective April 22, 2026, BPC-157 was removed from Category 2 (the bulks substances list flagged as raising significant safety concerns)
BPC-157/TB-500 10MG (Blend) is supplied as a lyophilised (freeze-dried) powder
Suitable for Most Skin Types: Especially beneficial for those concerned with dullness, dark spots, or uneven skin tone
US$ 24.58
US$ 22.48
US$ 20.74
US$ 23.27
US$ 20.85
US$ 24.55
